Agios Pharmaceuticals, Inc. · NASDAQ:AGIO
Vanguard Capital Management LLC reported a 5.27% stake in Agios Pharmaceuticals, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 29, 2026
Vanguard Capital Management LLC reported a 5.27% stake in Agios Pharmaceuticals, Inc., 3,088,169 shares, as a passive investor on Mar 31, 2026. Filed Apr 29, 2026 (Schedule 13G).
- Stake
- 5.27%
- Shares
- 3,088,169
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.27% | 3,088,169 |
Source
Related
- Agios Pharmaceuticals, Inc.
- Vanguard Capital Management LLC
- Agios Pharmaceuticals, Inc. shareholders
- Form 4 · Gheuens Sarah · Aug 6, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 3, 2026
- Form 4 · Backstrom Jay T. · Jul 10, 2026
- Form 4 · Gheuens Sarah · Jul 2, 2026
- Schedule 13G · D. E. Shaw & Co., L.P. · Jul 2, 2026